Low-Density Lipoprotein Receptor Gene Mutations and Cardiovascular Risk in a Large Genetic Cascade Screening Population
- 10 December 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (24) , 3031-3036
Abstract
Background— A large cohort of patients with familial hypercholesterolemia (FH), free from selection for cardiovascular disease (CVD), and their unaffected relatives was collected by genetic cascade screening and examined for the influence of different mutations of the LDL receptor gene on lipoprotein levels and the risk of CVD. Multivariate analyses with adjustment for age, sex, and specific family ties were performed. Methods and Results— Significant variation of LDL levels was observed among 399 patients with FH with different mutations. Null alleles were associated with more severely elevated LDL cholesterol, whereas the frequent N543H/2393del9 mutation led to less elevated LDL cholesterol. The type of mutation did not influence HDL cholesterol levels. Patients with FH had CVD 8.5 times more often compared with their unaffected relatives (RR, 8.54; 95% CI, 5.29 to 13.80). The N543H/2393del9 mutation was associated with a smaller increase of risk compared with other mutations ( P Conclusions— LDL receptor mutations only partly contributed to the variation of LDL cholesterol levels and cardiovascular burden in FH. Additional, so far unidentified, familial risk factors must underlie the differences of CVD risk, most likely independent of lipids and lipoproteins.Keywords
This publication has 14 references indexed in Scilit:
- The molecular basis of familial hypercholesterolemia in The NetherlandsHuman Genetics, 2001
- Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality studyCommentary: Role of other genes and environment should not be overlooked in monogenic diseaseBMJ, 2001
- Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trialThe Lancet, 2001
- Review of first 5 years of screening for familial hypercholesterolaemia in the NetherlandsThe Lancet, 2001
- Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemiaAtherosclerosis, 2000
- Molecular genetic testing for familial hypercholesterolemia: spectrum of LDL receptor gene mutations in the NetherlandsClinical Genetics, 2000
- Mutation screening and genotype:phenotype correlation in familial hypercholesterolaemiaAtherosclerosis, 1999
- Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular diseaseAtherosclerosis, 1999
- Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25–49 years) versus middle-aged (50–64 years) menAtherosclerosis, 1999
- Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemiaThe Lancet, 1993